title: N-terminal probrain natriuretic peptide and patent ductus arteriosus in preterm infants.
abstract: OBJECTIVE
  To determine whether plasma N-terminal probrain natriuretic peptide (NT-proBNP) in premature infants could identify hemodynamically significant patent ductus arteriosus (HsPDA) and to determine the correlation between serial plasma NT-proBNP and echocardiographic assessment of ductal shunting.
  
  
  METHODS
  An observational study involving 35 preterm infants who underwent echocardiographic assessment for PDA on day 2, 4 and 7 of life with simultaneous blood sampling for determination of NT-proBNP concentrations. HsPDA was diagnosed by left-to-right ductal shunt on color Doppler, measuring diameter >1.5 mm on two-dimensional echocardiography plus > or =2 clinical features of PDA.
  
  
  RESULTS
  Plasma NT-proNBP levels on day 2 in the HsPDA group (n=12) were significantly higher than in non-HsPDA group (n=23) with a median of 16,353 pg ml(-1) (interquartile range (IQR), 12,360-33,459; range, 10,316-104,998) vs 3914 pg ml(-1) (IQR, 2601-5782; range, 1535-19,516) (P<0.001), respectively. Eight infants (67%) in the HsPDA group responded to an initial course of indomethacin or ibuprofen and their NT-proBNP levels significantly decreased within 48 h after treatment compared with non-responders (P=0.007). NT-proBNP concentrations were significantly correlated with left atrial to aortic root ratio. A cut-off NT-proBNP on day 2 of 10,180 pg ml(-1) offered the best predictive values for HsPDA with a sensitivity of 100% and a specificity of 91%.
  
  
  CONCLUSIONS
  Plasma NT-proBNP on day 2 was found as a sensitive marker for predicting HsPDA in preterm infants. Successful closure of PDA was also correspondent with the decline in plasma NT-proBNP.
authors.affiliation: Department of Pediatrics, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand. tepnt@mahidol.ac.th
authors.forename: P
authors.initials: P
authors.lastname: Nuntnarumit
authors.forename: A
authors.initials: A
authors.lastname: Khositseth
authors.forename: P
authors.initials: P
authors.lastname: Thanomsingh
mesh_terms: D015415:Biomarkers; D004374:Ductus Arteriosus, Patent / Q000097:blood* / Q000000981:diagnostic imaging*; D004452:Echocardiography; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007233:Infant, Postmature / Q000097:blood*; D008297:Male; D020097:Natriuretic Peptide, Brain / Q000097:blood*; D010446:Peptide Fragments / Q000097:blood*; D011446:Prospective Studies; D012680:Sensitivity and Specificity; D012720:Severity of Illness Index
chemical_list: D015415:Biomarkers; D010446:Peptide Fragments; C109794:pro-brain natriuretic peptide (1-76); D020097:Natriuretic Peptide, Brain